NEUROLOGIE PRO PRAXI / Neurol. praxi. 2024;25(5):406-413 / www.neurologiepropraxi.cz 412 Z HISTORIE NEUROLOGIE Progresivní supranukleární paralýza a guamský parkinsonský komplex aneb Kanaďan v Tichomoří: John C. Steele (1934–2022) a nakonec spoluautorizoval přehledný článek, který hypotézu označil za jedinou správnou (Menšíková et al., 2023). Začátkem roku 2022 při přípravě tohoto článku v korespondenci se spoluautory připustil (na přímou výzvu Petera Spencera) to, že důkazů o environmentálním původu ALS/PDC je již příliš mnoho a že chronická intoxikace BMAA a MAM u domorodců s (patrně) genetickou susceptibilitou může být tím skutečným důvodem manifestace onemocnění. Praktické vymizení nových případů ALS/PDC potom vysvětlil importem potravin z pevniny, které vytlačily tradiční jídla včetně cykasových tortill. John Steele zemřel na Bali 21. května 2022. Přál si, aby jeho děti rozprášily jeho popel do moře v blízkosti Candidase na jihovýchodním cípu ostrova. Poděkování Autoři děkují Mgr. Kláře Čebišové z Ústavu jazyků Lékařské fakulty UK v Hradci Králové, doc. PhDr. Vítu Huškovi, Ph.D., děkanovi Teologické fakulty UP v Olomouci a prof. MUDr. Ing. Petrovi Hluštíkovi, Ph.D., z Neurologické kliniky LF UP, za pomoc při překladu Strobachova historického textu. LITERATURA 1. Banack SA, Cox PA. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam. Neurology. 2003;61(3):387-9. 2. Barbeau A. Dégénérescence plurisystématisée du névraxe. Syndrome de Steele-Richardson-Olszewski [Plurisystematic degeneration of the neuraxis. Steele-Richardson-Olszewski syndrome]. Union Med Can. 1965;94:715-8. 3. Belaústegui Fernández A. 2015. Sanitarios militares en las Islas Marianas, 1521–1898. La lucha contra el olvido. Islas Marianas: Ministerio de Defensa, Secretaría General Técnica. Centro de Publicaciones. 4. Colosimo C, Bak TH, Bologna M, Berardelli A. Fifty years of progressive supranuclear palsy. J Neurol Neurosurg Psychiatr. 2014;85:936-942. 5. Cox PA, Banack SA, Murch SJ. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc Natl Acad Sci U S A. 2003;100(23):13380-3. 6. Foss AJ, Chernoff N, Aubel MT. The analysis of undervaterizated ß-methylamino-L-alanine (BMAA), BAMA, AEG & 2,4-DAB in Pteropus mariannus mariannus specimens using HILIC -LC-MS/ MS. Toxicon. 2018;152:150-159. 7. Gajdusek DC, Salazar AM. Amyotrophic lateral sclerosis and parkinsonian syndromes in high incidence among the Auyu and Jakai people of West New Guinea. Neurology. 1982;32:107-126. 8. Gajdusek DC. Cycad toxicity not the cause of high-incidence amyotrophic lateral sclerosis/ parkinsonism-dementia on Guam, Kii peninsula of Japan, or West New Guinea. In: Hudson AJ, editor. Amyotrophic lateral sclerosis – concepts in pathogenesis and etiology. Toronto: University of Toronto Press. 1990; p: 317-325. 9. Gibbs CJ Jr, Gajdusek DC. Amyotrophic lateral sclerosis, Parkinson's disease, and the amyotrophic lateral sclerosis-Parkinsonism-dementia complex on Guam: a review and summary of attempts to demonstrate infection as the aetiology. J Clin Pathol Suppl (R Coll Pathol). 1972;6:132-40. 10. Giménez-Roldán S, Steele JC, Palmer VS, Spencer PS. Lytico- -bodig in Guam: Historic links between diet and illness during and after Spanish colonization. J Hist Neurosci. 2021;30:335- 374. 11. Guam Vital Statistics Report.1823. Micronesia Area Research Center. https://www.uog.edu. 12. Hirano A, Kurland LT, Kroth RS, Lessell S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. I. Clinical features. Brain. 1961;84:642-61(a). 13. Hirano A, Malamud N, Kurland LT. Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. Brain. 1961;84:662-79(b). 14. Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord. 2017;32(6):853-864. 15. Kaňovský P. Atypický parkinsonismus: Progresivní supranukleární paralýza. In: Růžička E, Roth J, Kaňovský P. Parkinsonova nemoc a parkinsonské syndromy, Galén, Praha 2001, s. 165-170. 16. Kimura K, Yase Y, Higashi Y, et al. Epidemiological and geomedical studies on ALS and allied diseases in Kii peninsula (Japan). Preliminary report. Proc Jpn Acad. 1961;37:417-420. 17. Kisby GE, Ellison M, Spencer PS. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros. Neurology. 1992;42:1336-40. 18. Klatzo, I, Gajdusek DC, Zigas V. Pathology of kuru. Lab Invest. 1959;8:799-847. 19. Klatzo, I. Jerzy Olszewski, M. D., Ph.D. Acta Neuropathol. 1964;3:531. 20. Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. 1. Preliminary report of geographical distribution with special reference to the Mariana Islands including clinical and pathological observations. Neurology. 1954;4:438-448. 21. Kurland LT, Hirano A, Malamud N, Lessel S. Parkinsonism-dementia complex, an endemic disease on the island of Guam. Clinical, pathological, genetic and epidemiological features. Trans Am Neurol Assoc. 1961;86:115-20. 22. Kurland LT. An appraisal to the neurotoxicity of cycad and the etiology of amytrophic lateral sclerosis on Guam. Fed Proc. 1972;31:1540-2. 23. Menšíková K, Kaňovský P, Steele JC. Progresivní supranukleární paralýza. In: Menšíková K, Kaňovský P, Bareš M. Atypické parkinsonské syndromy. Galén, Praha 2015, ss. 121-136. 24. Menšíková K, Steele JC, Rosales R, et al. Endemic parkinsonism: clusters, biology and clinical features. Nat Rev Neurol. 2023;19:599-616. 25. Mulder DW, Kurland LT, Iriarte LLG. Neurologic diseases on the island of Guam. U. S. Armed Forces Med. J. 1954;5:1724.39. 26. Plato CC, Reed DM, Elizan TS, Kurland LT. Amyotrophic lateral sclerosis- Parkinsonism-dementia complex of Guam. IV. Familial and genetic investigations. Am J Hum Genet. 1967;19(5):617-32. 27. Respondek G, Grimm MJ, Piot I, et al. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies. Mov Disord. 2020;35(1):171-176. 28. Richardson JC, Steele J, Olszewski J. Supranuclear ophtalmophlegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of „heterogenous system degeneration“. Trans Am Neurol Assoc. 1963;88:25-9. 29. Sacks O. The Island of Colorblind. Doubleday/Knopf, New York 1997. 30. Spatz M, Hossman KA. In memory of Igor Klatzo, 1916–2007. J Neuropathol Exp Neurol. 2008; 67:170–171. 31. Spencer P, Nunn PB, Hugon J, et al. Guam amytrophic lateral sclerosis – parkinsonism – dementia linked to a plant excitant neurotoxin. Science. 1987;237:517-22(a). 32. Spencer PS, Palmer V, Ohta M, Herman A. Cycad, a suspect etiological factor for Guam ALS/P-D, is associated with motor neuron disease in Irian Jaya, Indonesia, and Kii Peninsula, Japan. In: Tsubaki T, Yase Y, editors. Amyotrophic lateral sclerosis: recent advances in research and treatment. Amsterdam: Excerpta Medica; 1988. p 35-40. 33. Spencer PS, Garner CE, Palmer VS, Kisby GE. Vervets and macaques: similarities and differences in their responses to L-BMAA. Neurotoxicology. 2016;56:284-286. 34. Spencer PS, Palmer VS. Food plant chemicals linked with neurological and neurodegenerative disease. Adv Neurotoxicol. 2017;1:247-267. 35. Spencer PS, Palmer VS, Kisby GE. Cycad β-N-methylamino-L- -alanine (BMAA), methylazoxymethanol, genotoxicity, and neurodegeneration. Toxicon. 2018;155:49-50. 36. Spencer PS. Hypothesis: etiologic and molecular mechanistic leads for sporadic neurodegenerative diseases based on experience with Western Pacific ALS/PDC. Front Neurol. 2019;10:754. 37. Spencer P, Palmer VS, Kisby GK. Western Pacific ALS- -PDC: Evidence implicating cycad neurotoxins. J Neurol Sci. 2020;419:117185(a). 38. Spencer PS. Parkinsonism and motor neuron disorders: lessons from the Western Pacific. J Neurol Sci. 2022;433:120021. 39. Stamelou M, Respondek G, Giagkou N, et al. Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies. Nat Rev Neurol. 2021;17(10):601-620. 40. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. a heterogenous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 1964;10:333-359. 41. Steele JC. Progressive supranuclear palsy. Brain. 1972;95(4):693704. 42. Wherrett JR. In memoriam: John Clifford Richardson MD, BSc., FRCP(C), FRCP (1909–1986). Can J Neurol Sci. 1986;13:292293. 43. Steele JC, Guzman T. Observations about amyotrophic lateral sclerosis and the parkinsonism-dementia complex of Guam with regard to epidemiology and etiology. Can J Neurol Sci. 1987;14(Suppl. 3):358-62. 44. Steele JC, Caparros-Lefebvre D, Lees AJ, Sacks OW. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism. Parkinsonism Relat Disord. 2002;9(1):39-54. 45. Steele JC, Wresch R, Hanlon SD, et al. A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam. Mov Disord. 2015;30(9):1271-5. 46. Strasser U. Missionary men in the modern world: German Jesuits and Pacific Journeys. Amsterdam University Press, Amsterdam 2020. 47. Strobach A. Relatio Rerum Notabilium in Marianas. Guam 1682-83, transcription “P“: National Archive, Prague, JS III 419/3; fol. 239r -241. 48. Whitwell J. Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum. Curr Opin Neurol. 2023;36(4):283-290. 49. Williams D, Lees AJ, Wherrett J, Steele JC. J. Clifford Richardson and 50 years of progressive supranuclear palsy. Neurology. 2008;70:566-573. 50. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270-9. 51. Zavadil P. Bohemia Jesuitica in Indiis Occidentalibus. Latinská korespondence českých jezuitů z Ameriky, Filipín a Marian v českých a moravských archivech, kritická edice. Disertační práce, Univerzita Karlova, Praha 2011. 52. Zimmerman HM. Progress report of work in the laboratory of pathology during May, 1945. Guam, US Naval Medical Research Unit No. 2, June 1. (unpublished navy memorandum, sealed “secret”). Washington, DC: Department of the Navy, 1945.
RkJQdWJsaXNoZXIy NDA4Mjc=